The goal is not to replicate the brain in miniature, but to reconstruct its organizing principles in an experimentally accessible system, offering new insights into human neural complexity while advancing neuroscience and medicine.
Abstract
Neural organoids have transformed experimental neuroscience by enabling human-specific models of brain development, function, and disease. Emerging at the intersection of stem cell biology and tissue engineering, these self-organizing systems recapitulate key aspects of neurogenesis, gliogenesis, and circuit formation within a controllable in vitro context. Advances in guided patterning, vascularization, and electrophysiological monitoring have enhanced structural and functional fidelity, enabling the study of dynamic processes previously inaccessible in human models. Beyond developmental biology, neural organoids have broad translational applications, including modeling neurodevelopmental and neurodegenerative disorders, screening pharmacological compounds, and testing regenerative strategies. Integration with microfluidics, bioelectronic interfaces, and computational modeling further expands their analytical capacity, transforming organoids into modular and quantifiable platforms for mechanistic and therapeutic discovery. Despite this progress, key challenges remain, including limited maturation, inter-organoid variability, and incomplete physiological integration. Addressing these limitations requires standardized differentiation protocols, robust functional benchmarks, and cross-disciplinary collaboration. The goal is not to replicate the brain in miniature, but to reconstruct its organizing principles in an experimentally accessible system. From this perspective, neural organoids serve as a bridge between biology and technology, offering new insights into human neural complexity while advancing neuroscience and medicine.
Abstract Brain organoids provide three‐dimensional human cellular systems that can reproduce selected features of early neural development, regional patterning, cellular diversification, and emerging neural activity more effectively than conventional two‐dimensional cultures. However, their translational value depends not only on morphological resemblance to brain tissue, but also on whether construction strategies, functional validation, reproducibility, and application‐specific model fitness are appropriately aligned. This structured narrative review synthesizes representative engineering strategies for brain organoid construction and examines how cell source, embryoid body formation, extracellular matrix support, patterning strategy, culture platform, vascularization, and cellular complexity influence functional validation and translational applicability. We further organize functional assessment into a hierarchical validation framework that includes morphology and growth, lineage and regional identity, tissue viability, synaptic maturation, electrophysiological activity, neurochemical signaling, BBB‐like function, and omics‐based benchmarking. These advances support the use of brain organoids in developmental biology, neurological disease modeling, drug screening, neurovascular research, and exploratory biohybrid interfaces, although their interpretation remains constrained by immature cellular states, incomplete vascular perfusion, batch variability, and limited standardization. Overall, this review reframes brain organoids as engineered biological platforms whose value should be judged by the alignment among construction strategy, biological benchmark, functional readout, and intended translational application. The emphasis is comparative conceptual synthesis of engineering strategies and multi‐layer functional validation rather than systematic quantitative meta‐analysis.
Guohong Huang, Chenfei Lu, Zi-Han Jin et al.· Bioengineering & Translation...· 0 citations
A function-first framework in which regenerative organoids are engineered and evaluated according to measurable therapeutic outcomes, including tissue-specific function, vascular integration, immune compatibility, reproducibility, scalability, and long-term stability is proposed.
Recent advances in biomedical research have increased demand for experimental systems capable of capturing human biological processes with greater physiological relevance than traditional approaches. However, direct investigation of cellular dynamics remains constrained by the invasive nature of many methodologies, the limited viability of human tissue samples, and the translational shortcomings of animal models. Organoid technology has emerged as a powerful alternative, enabling the generation of three-dimensional tissue-like structures from pluripotent or adult stem cells that reproduce key structural and functional characteristics of native organs. Through self-organisation and preservation of donor-specific genetic information, organoids provide physiologically representative platforms for studying disease mechanisms, host–pathogen interactions, therapeutic responses, and interindividual variation.
The present narrative review outlines the scientific foundations underpinning organoid development, tracing their emergence from advances in tissue engineering and three-dimensional culture systems. The limitations of conventional in vitro and in vivo models are examined alongside the advantages offered by organoid platforms for long-term investigation of human physiology and pathology. Particular emphasis is placed on their growing role in precision medicine, including disease modelling, drug discovery, toxicity assessment, and patient stratification. Emerging applications in regenerative medicine and transplantation are also discussed, together with current technical challenges such as vascularisation and tissue integration. Collectively, organoid systems represent a transformative tool for biomedical research, offering new opportunities to improve and personalise therapeutic strategies, ultimately advancing translational medicine.
The critical roles of hemodynamic cues, including shear stress and perfusion, together with metabolic and immune signaling, in driving the coordinated maturation of endothelial and mural compartments are highlighted.
Chonggui Jiang, Pan Cui, Liyan Gong· Vascular pharmacology· 0 citations
Organoid research has fundamentally reshaped in vitro approaches to modeling disease, drug response, and developmental processes. While the potential is great, the technology is limited by reproducibility and physiological accuracy challenges that arise partly from the shortcomings in extracellular matrix mimicking biomaterials that influence morphogenesis, differentiation, and functionality. In recent years, biomaterials for organoid systems have developed from biologically derived but poorly defined matrices toward tunable, dynamic, and modular systems that allow for precise control and better reproducibility of the microenvironment. This Mini-Review summarizes recent advances, with a focus on the last 3 years, in natural, synthetic, and hybrid biomaterials, highlighting engineered ECM–derived hydrogels, modified natural polymers, and synthetic systems with tunable viscoelasticity, degradability, and bioactive components. Furthermore, emerging trends and technological integrations, comprised of 3D and 4D bioprinting, granular hydrogels, organ-on-a-chip platforms, and AI-driven methods, will be discussed, which together support scalable and data-driven optimizations in organoid research. Summarized, these developments demonstrate the transition from a generic matrix-based culture toward engineered, tunable, and dynamic microenvironments, demonstrating biomaterial design as a fundamental element for next-generation organoid systems.
Laura Klasen, Ramin Nasehi, Lennart Selzener et al.· Frontiers in Bioengineering...· 0 citations
Two cases in which organoid-derived findings enabled FDA-approved clinical trials are highlighted, illustrating how organoids can reveal disease mechanisms that are inaccessible or incompletely reproduced in animal models.
A. A. Martins, A. Muotri· Stem Cells and Development· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
